OKLAHOMA CITY (Aug. 14, 2026) – Attorney General Gentner Drummond announced today that eight opioid drug manufacturers will pay Oklahoma approximately $12 million as part of a multi-state settlement over allegations that the companies contributed to the national opioid crisis.
Oklahoma has reached settlements with Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun Pharma and Zydus. Funds will be utilized for opioid remediation strategies and will reach Oklahoma communities through grant allocations.
Drummond said the settlements are key in the state’s fight to overcome Oklahoma’s deadly opioid epidemic.
“I am committed to fighting Oklahoma’s opioid crisis at every level,” Drummond said. “Funds from these settlements will provide critical tools and resources to combat the opioid epidemic and save lives.”
Drummond’s office has already awarded nearly $30 million in grants to communities across Oklahoma to fight against opioid abuse. In 2020, the Oklahoma Legislature created the Opioid Abatement Board to manage opioid settlement funds and support efforts to combat the crisis. When Drummond took office in 2023, he distributed the first round of opioid abatement grants. The fourth allocation of grant awards will be made this month. Yesterday, the Opioid Abatement Board approved Drummond's recommendation to award more than $12 million in grants to cities, counties and public trusts.
Grants support treatment and recovery programs, assistance with co-occurring disorders and mental health issues, opioid abuse education and prevention, proper prescription efforts and strategies to decrease the supply of narcotics across the state.
